1-3 of 3
Linda Williams
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Sequential Immunization of Melanoma Patients with GD3 Ganglioside Vaccine and Anti-Idiotypic Monoclonal Antibody That Mimics GD3 Ganglioside

Paul B. Chapman, Dianna Wu, Govind Ragupathi, Sharon Lu, Linda Williams, Wen-Jen Hwu, Diantha Johnson, Philip O. Livingston
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (14): 4717–4723.
https://doi.org/10.1158/1078-0432.CCR-04-0345
Published: 21 July 2004
View article titled, Sequential Immunization of Melanoma Patients with GD3 Ganglioside Vaccine and Anti-Idiotypic Monoclonal Antibody That Mimics GD3 Ganglioside
Open the PDF for Sequential Immunization of Melanoma Patients with GD3 Ganglioside Vaccine and Anti-Idiotypic Monoclonal Antibody That Mimics GD3 Ganglioside in another window
Journal Articles

T-Cell Responses against Tyrosinase 368–376(370D) Peptide in HLA∗A0201+ Melanoma Patients: Randomized Trial Comparing Incomplete Freund’s Adjuvant, Granulocyte Macrophage Colony-stimulating Factor, and QS-21 as Immunological Adjuvants

Susanne G. Schaed, Virginia M. Klimek, Katherine S. Panageas, Cristina M. Musselli, Leah Butterworth, Wen-Jen Hwu, Philip O. Livingston, Linda Williams, Jonathan J. Lewis, Alan N. Houghton, Paul B. Chapman
Journal: Clinical Cancer Research
Clin Cancer Res (2002) 8 (5): 967–972.
Published: 01 May 2002
View article titled, T-Cell Responses against Tyrosinase 368–376(370D) Peptide in HLA∗A0201<sup>+</sup> Melanoma Patients: <subtitle>Randomized Trial Comparing Incomplete Freund’s Adjuvant, Granulocyte Macrophage Colony-stimulating Factor, and QS-21 as Immunological Adjuvants</subtitle>
Open the PDF for T-Cell Responses against Tyrosinase 368–376(370D) Peptide in HLA∗A0201<sup>+</sup> Melanoma Patients: <subtitle>Randomized Trial Comparing Incomplete Freund’s Adjuvant, Granulocyte Macrophage Colony-stimulating Factor, and QS-21 as Immunological Adjuvants</subtitle> in another window
Journal Articles

Vaccination with a Bivalent GM2 and GD2 Ganglioside Conjugate Vaccine: A Trial Comparing Doses of GD2-Keyhole Limpet Hemocyanin

Paul B. Chapman, Donna Morrisey, Katherine S. Panageas, Linda Williams, Jonathan J. Lewis, Robert J. Israel, W. Bradley Hamilton, Philip O. Livingston
Journal: Clinical Cancer Research
Clin Cancer Res (2000) 6 (12): 4658–4662.
Published: 01 December 2000
View article titled, Vaccination with a Bivalent G<sub>M2</sub> and G<sub>D2</sub> Ganglioside Conjugate Vaccine: A Trial Comparing Doses of G<sub>D2</sub>-Keyhole Limpet Hemocyanin
Open the PDF for Vaccination with a Bivalent G<sub>M2</sub> and G<sub>D2</sub> Ganglioside Conjugate Vaccine: A Trial Comparing Doses of G<sub>D2</sub>-Keyhole Limpet Hemocyanin in another window